This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Healthcare Analytical Testing Services Market

Healthcare stakeholders in a bid to curtail product recalls to invest more in Healthcare Analytical Testing Services: Opportunities ahead

Healthcare Analytical Testing Services Market by Product Type & Region - Forecast 2022 – 2032

Healthcare Analytical Testing Services Market Overview 2022-2032

According to an analysis by Future Market Insights, the global Healthcare Analytical Testing Services Market was valued at around US$ 11.9 Bn in 2021. With a projected CAGR of 14% for the next ten years, the market is likely to reach a valuation of US$ 49.6 Bn by the end of 2032.

Attributes

Details

Healthcare Analytical Testing Services Market Size (2021)

US$ 11.9 Bn

Healthcare Analytical Testing Services Market Size (2022)

US$ 13.5 Bn

Projected Market Value (2032)

US$ 49.6 Bn

Global Market Growth Rate (2022-2032)

14%

US Market Growth Rate (2022-2032)

14.5%

Key Companies Profiles

  • Eurofins Scientific
  • Pace Analytical Services LLC
  • Intertek Group
  • Toxikon, Inc.
  • SGS SA
  • Syneos Health
  • Charles River Laboratories International Inc.
  • Labcorp
  • ICON plc
  • WUXI Apptec

Future Market Insights’ analysis reveals that most of the Healthcare Analytical Testing Services market revenue is grossed from Pharmaceutical Testing, which has a forecasted CAGR of 13.2% by 2032. The US is the leading market, with a forecasted market size of US$ 19 Bn in 2032. The changing regulatory landscape, the need to avoid unfeasible investments and the need to reduce or eliminate the risk of product recalls to the highest degree possible are major drivers for the Healthcare Analytical Testing Services market.

Customize this Report

Let us know your requirement to get
100% FREE customization

Why are manufacturers choosing to outsource their Healthcare Analytical Testing to service providers?

Healthcare manufacturers and researchers dealing with a highly regulated and competitive market are turning to outsourcing their analytical testing to testing service providers. Outsourcing is a solution to the problem of a lack of resources and expertise a company might face if they choose to conduct their testing in-house. There is also a cost benefit, since there is a reduction in fixed capital requirements and operating costs since laboratories can be contacted as and when necessary.

Due to the nature of their products, companies are willing to ensure high quality testing even when under strict budgets. Several organizations use outsourcing as a means to perform routine tests in order to reduce the time spent in the product process for a more efficient and timely rollout of products. Further, the use of reputed agencies lends further credibility to products due to the lower chances of an internal bias. The combination of these factors is giving a significant boost to the market.

Why is the increase in product recalls and regulatory requirements affecting the?

Product recalls are a key concern in the healthcare industry, with the estimated cost of a recall to a manufacturer being over US$ 600 million on average. Estimates place around half of the recall costs to pharmaceutical companies that actually occur due to this business interruption. The high-risk and sensitive nature of healthcare products means that ethics are also a key concern.

Even a single flaw can lead to severe consequences on actual human life, and thus ensuring near-perfect safety is essential for both companies and official regulatory bodies. This means that there are highly strict monitoring guidelines and regulatory processes in place for both new and existing products. Efficient and thorough testing is vital to meeting these requirements. This nature of the products and the attempts to reduce recall are expected to be significant drivers for demand in the future as well.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is the testing of packaging materials contributing to demand?

The WHO reports that healthcare-acquired infections are a prominent cause for concern. Ensuring that the packaging selected for healthcare products is efficient is an essential component of producing these products. Even if products themselves are sterilized, the manufacturers must ensure through testing that the product will remain the same even through changes in the environment, human handling, and various other parts of the production and distribution process. They must also test for changes in the efficacy of the packing over time under varied conditions the final object is likely to be subject to.

How is the testing of Extractable and Leachable affecting the Healthcare Analytical Testing Services market?

A growing concern in recent years is Extractable and Leachable Testing. Extractables, which migrate from the product under stressed conditions, and Leachables, which migrate from the product under normal conditions, are extremely harmful since they can cause a change in the product itself. Since they directly interact with a pharmaceutical or medical product at any stage of the production process, they are in the spotlight of regulatory concern, with regulations demanding more thorough tests than the base ISO testing covers.

Before stringent rules were in place, Extractables and Leachables caused significant adverse events in the healthcare environment, For example, in 2002 the FDA had to release a notification regarding the presence of DEHP, which is a widely used plasticizer in PVC products. Traces of DEHP were found in Total Parenteral Nutrition fat emulsion infusion lines. Vanillin was another such substance, which was found in inhalation solutions within LDPE containers. A foil overwrap had to be introduced to prevent the migration of this substance once it was identified, which led to time delays and significant costs to recover from.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Region-wise Insights

How has Europe become an emerging region for Global Healthcare Analytical Testing Services market?

Europe is an emerging region for the demand in Healthcare Analytical Testing Services market. Regulations for medical devices in the European Union are under the MDR or Medical Device Regulation, which is currently in an adjustment period till 2024 after coming into effect in 2021. With the growing healthcare expenditure of the European countries, the revenue through healthcare analytical testing services is also expected to swell.

Country-wise Insights

U.S. Healthcare Analytical Testing Services Market Analysis

The United States is the nucleus of Global Medical Device Testing demand, having witnessed a CAGR of 12.6% during 2017 - 2021, and with a market value of US$ 19 Bn by 2032 at a CAGR of 14.5% during 2022 – 2032. Medical devices in the US are categorized by the FDA from CLASS I to class III based on the risk they pose. Testing differs amongst classes, with the higher classes requiring far more stringent testing. The FDA regulates pharmaceuticals as well, with the main regulatory standard being the Current Good Manufacturing Practices or GMPs regulation.

U.K. Healthcare Analytical Testing Services Market Analysis

Healthcare analytical testing services market in the UK is projected to reach a valuation of US$ 2.2 Bn by 2032. The Healthcare Analytical Testing Services market in the country is expected to gross an absolute dollar opportunity of US$ 1.6 Bn during 2022 – 2032, with a CAGR of 14%.

Japan Healthcare Analytical Testing Services Market Analysis

The Healthcare Analytical Testing Services market in Japan is expected to gross an absolute dollar opportunity of US$ 2.2 Bn during 2022 - 2032. The market is projected to reach a valuation of US$ 2.7 Bn by 2032, growing at a CAGR of 18.6% during 2022 – 2032.

South Korea Healthcare Analytical Testing Services Market Analysis

The Healthcare Analytical Testing Services market in South Korea is expected to reach a valuation of US$ 987.4 Mn by 2032. The market in the country is expected to register an absolute dollar opportunity of US$ 704.6 Mn between 2020 and 2032.

China Healthcare Analytical Testing Services Market Analysis

China is a key country for demand, having witnessed a CAGR of 16.8%, with an absolute dollar opportunity of US$ 3.1 Bn and a forecasted 2032 market size of US$ 4.2 Bn a CAGR of 13.9%. The demand is largely due to the strict regulatory demands by authorities. The regulation of healthcare products is handled by the National Medical Products agency, which was formerly the China Food and Drug Administration of CFDA, and is a part of the State Administration for Market Regulation.

Category-wise Insights

What product type is leading market demand for Healthcare Analytical Testing Services?

Pharmaceuticals are leading market demand, with a forecasted CAGR of 13.2%. The testing of pharmaceutical products is a highly complex and lengthy process, which requires sophisticated technology and a wide range of resources. In recent years, the increased scrutiny of final products has led to an increase in manufacturers and researchers turning to test services to ensure that their drugs have regulatory compliance.

Competitive Landscape

Healthcare Analytical Testing Service providers are focused on maintaining the quality of their services and finding efficient methods to continue testing in order to help their clients meet regulatory guidelines. The key companies operating include Eurofins Scientific, Pace Analytical Services, LLC, Intertek Group, Toxikon, Inc., SGS SA, Syneos Health, Charles River Laboratories International Inc., Labcorp, ICON plc, WUXI Apptec, and Pharmaceutical Product Development

Some of the recent development in Healthcare Analytical Testing Services Market are as follows:

  • In July 2022, Alliance Pharma announced the purchase of UK-based Drug Development Solutions. They plan to use this purchase to further expand their analytical, bioanalytical service offerings and laboratory capabilities.
  • In April 2022, Inotiv Inc. announced the acquisition of Histion LLC, a preclinical laboratory services provider.
  • In February 2022, The Center for Breakthrough Medicines announced an agreement with with BioAnalysis LLC. This agreement will grant the Center for Breakthrough Medicines’ clients access to BioAnalysis’s testing services.
  • In December 2021, Alcami Corp., a US-based CDMO announced the acquisition of Masy Systems, Inc. Through the acquisition, Alcami will gain access to Masy’s Pharma and biostorage offerings, while Masy will gain access to Alcami’s services, which amongst other services includes analytical services.
  • In May 2021, EAG Laboratories announced a 20,000 Square–foot, FDA registered, DEA licenced, IAO 9001:3015 and ISO 17025 accredited. The AMG laboratory in St. Louis, Mo. It will include dedicated spaces for particle isolation and identification, and instrumentation for biocompatibility testing.
  • In April 2019, Charles River Laboratories International, Inc. announced the acquisition of Citoxlab for approx. US $500 Mn. Citoxlab is a CRO specialising in, amongst other services, medical device testing

Similarly, recent developments related to companies manufacturing Healthcare Analytical Testing Services have been tracked by the team at Future Market Insights, which is available in the full report.

Key Segments Covered in Healthcare Analytical Testing Services Industry Survey

By Product Type:

  • Medical Device
    • Extractable & Leachable
    • Material Characterization
    • Physical
    • Bioburden
    • Sterility
    • Other Medical Devices
  • Pharmaceutical
    • Bioanalytical
    • Method Development & Validation
    • Stability
    • Other Services

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Frequently Asked Questions

The global Healthcare Analytical Testing Services market was valued at US$ 11.9 Bn in 2021 and is expected to grow to US$ 13.5 Bn by 2032.

The Healthcare Analytical Testing Services industry is set to witness a growth rate of 14% over the forecast period and be valued at US$ 49.6 Bn by 2032.

Pharmaceutical is the top Product Type in the Healthcare Analytical Testing Services Market.

ICON plc, Charles River Laboratories International Inc., Intertek Group, and Eurofins Scientific the key suppliers of Healthcare Analytical Testing Services.

US, UK, China, Japan and South Korea are expected to drive the most sales growth of Healthcare Analytical Testing Services.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Investment Feasibility Matrix

    3.6. PESTLE and Porter’s Analysis

    3.7. Regulatory Landscape

        3.7.1. By Key Regions

        3.7.2. By Key Countries

    3.8. Regional Parent Market Outlook

4. Global Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032

        5.3.1. Medical Device

            5.3.1.1. Extractable & Leachable

            5.3.1.2. Material Characterization

            5.3.1.3. Physical

            5.3.1.4. Bioburden

            5.3.1.5. Sterility

            5.3.1.6. Other Medical Devices

        5.3.2. Pharmaceutical

            5.3.2.1. Bioanalytical

            5.3.2.2. Method Development & Validation

            5.3.2.3. Stability

            5.3.2.4. Other Services

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032

6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    6.1. Introduction

    6.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    6.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        6.3.1. North America

        6.3.2. Latin America

        6.3.3. Europe

        6.3.4. Asia Pacific

        6.3.5. Middle East and Africa

    6.4. Market Attractiveness Analysis By Region

7. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    7.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    7.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        7.2.1. By Country

            7.2.1.1. U.S.

            7.2.1.2. Canada

        7.2.2. By Product Type

    7.3. Market Attractiveness Analysis

        7.3.1. By Country

        7.3.2. By Product Type

    7.4. Key Takeaways

8. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. Brazil

            8.2.1.2. Mexico

            8.2.1.3. Rest of Latin America

        8.2.2. By Product Type

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Product Type

    8.4. Key Takeaways

9. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Germany

            9.2.1.2. U.K.

            9.2.1.3. France

            9.2.1.4. Spain

            9.2.1.5. Italy

            9.2.1.6. Russia

            9.2.1.7. Rest of Europe

        9.2.2. By Product Type

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

    9.4. Key Takeaways

10. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. China

            10.2.1.2. Japan

            10.2.1.3. India

            10.2.1.4. South Korea

            10.2.1.5. Australia

            10.2.1.6. Rest of APAC

        10.2.2. By Product Type

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

    10.4. Key Takeaways

11. Middle East and Africa Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. South Africa

            11.2.1.2. Saudi Arabia

            11.2.1.3. UAE

            11.2.1.4. Israel

            11.2.1.5. Rest of MEA

        11.2.2. By Product Type

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

    11.4. Key Takeaways

12. Key Countries Market Analysis

    12.1. U.S.

        12.1.1. Pricing Analysis

        12.1.2. Market Share Analysis, 2021

            12.1.2.1. By Product Type

    12.2. Canada

        12.2.1. Pricing Analysis

        12.2.2. Market Share Analysis, 2021

            12.2.2.1. By Product Type

    12.3. Brazil

        12.3.1. Pricing Analysis

        12.3.2. Market Share Analysis, 2021

            12.3.2.1. By Product Type

    12.4. Mexico

        12.4.1. Pricing Analysis

        12.4.2. Market Share Analysis, 2021

            12.4.2.1. By Product Type

    12.5. Germany

        12.5.1. Pricing Analysis

        12.5.2. Market Share Analysis, 2021

            12.5.2.1. By Product Type

    12.6. U.K.

        12.6.1. Pricing Analysis

        12.6.2. Market Share Analysis, 2021

            12.6.2.1. By Product Type

    12.7. France

        12.7.1. Pricing Analysis

        12.7.2. Market Share Analysis, 2021

            12.7.2.1. By Product Type

    12.8. Spain

        12.8.1. Pricing Analysis

        12.8.2. Market Share Analysis, 2021

            12.8.2.1. By Product Type

    12.9. Italy

        12.9.1. Pricing Analysis

        12.9.2. Market Share Analysis, 2021

            12.9.2.1. By Product Type

    12.10. Russia

        12.10.1. Pricing Analysis

        12.10.2. Market Share Analysis, 2021

            12.10.2.1. By Product Type

    12.11. China

        12.11.1. Pricing Analysis

        12.11.2. Market Share Analysis, 2021

            12.11.2.1. By Product Type

    12.12. Japan

        12.12.1. Pricing Analysis

        12.12.2. Market Share Analysis, 2021

            12.12.2.1. By Product Type

    12.13. India

        12.13.1. Pricing Analysis

        12.13.2. Market Share Analysis, 2021

            12.13.2.1. By Product Type

    12.14. South Korea

        12.14.1. Pricing Analysis

        12.14.2. Market Share Analysis, 2021

            12.14.2.1. By Product Type

    12.15. Australia

        12.15.1. Pricing Analysis

        12.15.2. Market Share Analysis, 2021

            12.15.2.1. By Product Type

    12.16. South Africa

        12.16.1. Pricing Analysis

        12.16.2. Market Share Analysis, 2021

            12.16.2.1. By Product Type

    12.17. Saudi Arabia

        12.17.1. Pricing Analysis

        12.17.2. Market Share Analysis, 2021

            12.17.2.1. By Product Type

    12.18. UAE

        12.18.1. Pricing Analysis

        12.18.2. Market Share Analysis, 2021

            12.18.2.1. By Product Type

    12.19. Israel

        12.19.1. Pricing Analysis

        12.19.2. Market Share Analysis, 2021

            12.19.2.1. By Product Type

13. Market Structure Analysis

    13.1. Competition Dashboard

    13.2. Competition Benchmarking

    13.3. Market Share Analysis of Top Players

        13.3.1. By Regional

        13.3.2. By Product Type

14. Competition Analysis

    14.1. Competition Deep Dive

        14.1.1. Pharmaceutical Product Development

            14.1.1.1. Overview

            14.1.1.2. Product Portfolio

            14.1.1.3. Profitability by Market Segments

            14.1.1.4. Sales Footprint

            14.1.1.5. Strategy Overview

                14.1.1.5.1. Marketing Strategy

        14.1.2. ICON plc

            14.1.2.1. Overview

            14.1.2.2. Product Portfolio

            14.1.2.3. Profitability by Market Segments

            14.1.2.4. Sales Footprint

            14.1.2.5. Strategy Overview

                14.1.2.5.1. Marketing Strategy

        14.1.3. LabCorp

            14.1.3.1. Overview

            14.1.3.2. Product Portfolio

            14.1.3.3. Profitability by Market Segments

            14.1.3.4. Sales Footprint

            14.1.3.5. Strategy Overview

                14.1.3.5.1. Marketing Strategy

        14.1.4. Charles River Laboratories International Inc.

            14.1.4.1. Overview

            14.1.4.2. Product Portfolio

            14.1.4.3. Profitability by Market Segments

            14.1.4.4. Sales Footprint

            14.1.4.5. Strategy Overview

                14.1.4.5.1. Marketing Strategy

        14.1.5. Syneos Health

            14.1.5.1. Overview

            14.1.5.2. Product Portfolio

            14.1.5.3. Profitability by Market Segments

            14.1.5.4. Sales Footprint

            14.1.5.5. Strategy Overview

                14.1.5.5.1. Marketing Strategy

        14.1.6. SGS SA

            14.1.6.1. Overview

            14.1.6.2. Product Portfolio

            14.1.6.3. Profitability by Market Segments

            14.1.6.4. Sales Footprint

            14.1.6.5. Strategy Overview

                14.1.6.5.1. Marketing Strategy

        14.1.7. Toxikon, Inc.

            14.1.7.1. Overview

            14.1.7.2. Product Portfolio

            14.1.7.3. Profitability by Market Segments

            14.1.7.4. Sales Footprint

            14.1.7.5. Strategy Overview

                14.1.7.5.1. Marketing Strategy

        14.1.8. Intertek Group

            14.1.8.1. Overview

            14.1.8.2. Product Portfolio

            14.1.8.3. Profitability by Market Segments

            14.1.8.4. Sales Footprint

            14.1.8.5. Strategy Overview

                14.1.8.5.1. Marketing Strategy

        14.1.9. Pace Analytical Services, LLC

            14.1.9.1. Overview

            14.1.9.2. Product Portfolio

            14.1.9.3. Profitability by Market Segments

            14.1.9.4. Sales Footprint

            14.1.9.5. Strategy Overview

                14.1.9.5.1. Marketing Strategy

        14.1.10. Eurofins Scientific

            14.1.10.1. Overview

            14.1.10.2. Product Portfolio

            14.1.10.3. Profitability by Market Segments

            14.1.10.4. Sales Footprint

            14.1.10.5. Strategy Overview

                14.1.10.5.1. Marketing Strategy

15. Assumptions & Acronyms Used

16. Research Methodolog

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 3: North America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 4: North America Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 5: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 6: Latin America Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 7: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 8: Europe Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 9: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 10: Asia Pacific Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 11: Middle East and Africa Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 12: Middle East and Africa Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Mn) by Product Type, 2022-2032

Figure 2: Global Market Value (US$ Mn) by Region, 2022-2032

Figure 3: Global Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 4: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 5: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 6: Global Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 7: Global Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 8: Global Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 9: Global Market Attractiveness by Product Type, 2022-2032

Figure 10: Global Market Attractiveness by Region, 2022-2032

Figure 11: North America Market Value (US$ Mn) by Product Type, 2022-2032

Figure 12: North America Market Value (US$ Mn) by Country, 2022-2032

Figure 13: North America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 14: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 15: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 16: North America Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 17: North America Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 18: North America Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 19: North America Market Attractiveness by Product Type, 2022-2032

Figure 20: North America Market Attractiveness by Country, 2022-2032

Figure 21: Latin America Market Value (US$ Mn) by Product Type, 2022-2032

Figure 22: Latin America Market Value (US$ Mn) by Country, 2022-2032

Figure 23: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 24: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 25: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 26: Latin America Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 27: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 28: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 29: Latin America Market Attractiveness by Product Type, 2022-2032

Figure 30: Latin America Market Attractiveness by Country, 2022-2032

Figure 31: Europe Market Value (US$ Mn) by Product Type, 2022-2032

Figure 32: Europe Market Value (US$ Mn) by Country, 2022-2032

Figure 33: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 34: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 35: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 36: Europe Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 37: Europe Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 38: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 39: Europe Market Attractiveness by Product Type, 2022-2032

Figure 40: Europe Market Attractiveness by Country, 2022-2032

Figure 41: Asia Pacific Market Value (US$ Mn) by Product Type, 2022-2032

Figure 42: Asia Pacific Market Value (US$ Mn) by Country, 2022-2032

Figure 43: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 44: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 45: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 46: Asia Pacific Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 47: Asia Pacific Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 48: Asia Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 49: Asia Pacific Market Attractiveness by Product Type, 2022-2032

Figure 50: Asia Pacific Market Attractiveness by Country, 2022-2032

Figure 51: Middle East and Africa Market Value (US$ Mn) by Product Type, 2022-2032

Figure 52: Middle East and Africa Market Value (US$ Mn) by Country, 2022-2032

Figure 53: Middle East and Africa Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 54: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 55: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 56: Middle East and Africa Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 57: Middle East and Africa Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 58: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 59: Middle East and Africa Market Attractiveness by Product Type, 2022-2032

Figure 60: Middle East and Africa Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Healthcare Interoperability Solutions Market

Published : February 2022

Healthcare

Home Healthcare Software Market

Published : July 2020

Healthcare

Animal Healthcare Market

Published : September 2017

Healthcare

Healthcare IT Outsourcing Market

Published : July 2020

Google translate

Healthcare Analytical Testing Services Market